January 3, 2024 12:54 PM ESTUpdated January 4, 10:09 AM
FDA+

Up­dat­ed: FDA says it has no plans for Is­rael-based of­fice

Zachary Brennan

Senior Editor

Two Food and Drug Ad­min­is­tra­tion of­fi­cials met with the Is­raeli em­bassy on Dec. 14 in Sil­ver Spring, MD, to dis­cuss es­tab­lish­ing a new FDA of­fice …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Mer­ck buys in­to PD-1/VEGF space as Sum­mit comes for Keytru­da

BeiGene will re­brand to BeOne Med­i­cines, drop­ping name's link to Chi­na roots

Ex­clu­sive: As­cid­i­an CEO Michael Ehlers leaves Ap­ple Tree Part­ners for MPM BioIm­pact

FDA ap­proves PTC’s ul­tra-rare dis­ease gene ther­a­py for broad­er pa­tient pop­u­la­tion than Eu­rope

GSK makes case for Blenrep's re­turn with new blood can­cer sur­vival da­ta

sponsored

What Will It Take to Re­verse Fi­bro­sis in Pa­tients with Ad­vanced MASH?

A service from the Financial Times